Stockreport

Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study [Financial Post (Toronto, Ontario, Canada)]

Helius Medical Technologies, Inc. - Class A  (HSDT) 
PDF — Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy ® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment [Read more]